Company Badge
USPTO Data Jan 1 1976 - Sep 29 2026
11 Patents
#406 in San Francisco, CA
#6,528 in California
#27,470 in US
#51,671 in the World
Prosetta Antiviral, Inc.
Forward Citations = 12
13 inventors:
San Francisco, CA, United States of America
Prosetta Antiviral, Inc.
% Expired Patents = 36.4
CIPO Patents = 1
EPO Patents = 3
Forward Citations = 12
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Clarence R Hurt (8 out of 9 patents)
Vishwanath R Lingappa (8 out of 18 patents)
Andy Atuegbu (6 out of 14 patents)
4. Anatoliy Kitaygorodskyy (5 out of 6 patents)
5. Beverly Freeman (5 out of 5 patents)
6. Dennis Solas (2 out of 47 patents)
7. Jacob J Plattner (1 out of 105 patents)
8. Suganya Selvarajah (1 out of 1 patent)
9. Kumar Paulvannan (1 out of 2 patents)
10. Debendranath Dey (1 out of 1 patent)
11. Anatoliy Kitaygorodorskyy (1 out of 1 patent)
12. Colm Kelleher (1 out of 1 patent)
13. William Hansen (1 out of 1 patent)
14. Anatoliy Kityagorodskyy (0 patent)
11 patents:
Prosetta Antiviral, Inc. is a biotechnology company focused on developing novel antiviral drugs. Founded in 2002, the company's mission is to discover and develop therapeutics that address significant unmet medical needs in the field of viral diseases. Prosetta Antiviral utilizes a proprietary technology platform to identify drug candidates that target specific viral proteins, with the aim of disrupting viral replication and improving patient outcomes. With a strong team of scientists and strategic partnerships, Prosetta Antiviral is committed to making a positive impact in the fight against viral infections.
Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
1 patent (CIPO):
Please report any incorrect information to [email protected]
3 patents (EPO):
Please report any incorrect information to [email protected]